XML 89 R51.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Revenue - Disaggregation of Net Sales by Segment and Division (Details) - USD ($)
$ in Millions
12 Months Ended
Apr. 26, 2024
Apr. 28, 2023
Apr. 29, 2022
Disaggregation of Revenue [Line Items]      
Net sales $ 32,364 $ 31,227 $ 31,686
Reportable segment net sales      
Disaggregation of Revenue [Line Items]      
Net sales 32,142 30,731 30,959
Cardiovascular      
Disaggregation of Revenue [Line Items]      
Net sales 11,831 11,522 11,368
Cardiovascular | Cardiac Rhythm & Heart Failure      
Disaggregation of Revenue [Line Items]      
Net sales 5,995 5,783 5,852
Cardiovascular | Structural Heart & Aortic      
Disaggregation of Revenue [Line Items]      
Net sales 3,358 3,363 3,055
Cardiovascular | Coronary & Peripheral Vascular      
Disaggregation of Revenue [Line Items]      
Net sales 2,478 2,375 2,460
Neuroscience      
Disaggregation of Revenue [Line Items]      
Net sales 9,406 8,959 8,784
Neuroscience | Cranial & Spinal Technologies      
Disaggregation of Revenue [Line Items]      
Net sales 4,756 4,451 4,456
Neuroscience | Specialty Therapies      
Disaggregation of Revenue [Line Items]      
Net sales 2,905 2,815 2,592
Neuroscience | Neuromodulation      
Disaggregation of Revenue [Line Items]      
Net sales 1,746 1,693 1,735
Medical Surgical      
Disaggregation of Revenue [Line Items]      
Net sales 8,417 7,989 8,469
Medical Surgical | Surgical & Endoscopy      
Disaggregation of Revenue [Line Items]      
Net sales 6,508 6,152 6,543
Medical Surgical | Acute Care & Monitoring      
Disaggregation of Revenue [Line Items]      
Net sales 1,908 1,837 1,926
Diabetes      
Disaggregation of Revenue [Line Items]      
Net sales 2,488 2,262 2,338
Other operating segment      
Disaggregation of Revenue [Line Items]      
Net sales $ 221 $ 495 $ 727